Bristol Myers and Pfizer said on Thursday they will start selling their blockbuster blood thinner, Eliquis, directly to ...

Taking a page from Eli Lilly and Novo Nordisk, who have launched online programs to sell their diabetes and obesity drugs ...

Apixaban would still cost patients 9 times more through the Eliquis 360 Support program than with commercial insurance.

The direct-to-consumer (DTC) platform – called Eliquis 360 Support – will offer Eliquis (apixaban) to patients who pay for ...

The program is the latest example of pharmaceutical companies bypassing traditional drug distribution channels for people who ...

In advance of CMS’ negotiated price for the blood thinner taking effect next year, partners Bristol Myers Squibb and Pfizer ...

Pfizer, Inc. (NYSE:PFE) is one of the high-margin pharma stocks to buy now. Bristol-Myers Squibb Company (NYSE:BMY) and ...

Following in the footsteps of other pharmaceutical companies, Bristol Myers Squibb and Pfizer are offering Eliquis for cash-paying patients at a discount of 40% off the list price.

Eliquis brought in roughly 240,000 prescriptions in January of last year, while Xarelto saw over 600,00 in the same month. In September of this year, Eliquis brought in 667,000, compared with ...

Pfizer, in partnership with Bristol Myers Squibb, has launched a direct-to-patient sales strategy for Eliquis®, aiming to ...

Many studies have shown that even though these medicines have risks, these risks are much lower than the risk of a stroke ...

Sales of Eliquis, which Bristol-Myers shares with Pfizer Inc , rose 24% to $2.04 billion, while Orencia sales rose 9% to $778 million, both exceeding Wall Street expectations.